These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

943 related items for PubMed ID: 12365957

  • 1. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF, Escarce JJ, Solomon MD, Goldman DP.
    JAMA; 2002 Oct 09; 288(14):1733-9. PubMed ID: 12365957
    [Abstract] [Full Text] [Related]

  • 2. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.
    Arch Gen Psychiatry; 2005 Apr 09; 62(4):435-41. PubMed ID: 15809411
    [Abstract] [Full Text] [Related]

  • 3. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM, Urmie JM, Farris KB, Doucette WR.
    Res Social Adm Pharm; 2010 Jun 09; 6(2):100-9. PubMed ID: 20511109
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013.
    Brouwer ED, Basu A, Yeung K.
    Pharmacoeconomics; 2019 Oct 09; 37(10):1287-1300. PubMed ID: 31270747
    [Abstract] [Full Text] [Related]

  • 8. Pharmacy benefit spending on oral chemotherapy drugs.
    Curtiss FR.
    J Manag Care Pharm; 2006 Sep 09; 12(7):570-7. PubMed ID: 16981802
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
    Klepser DG, Huether JR, Handke LJ, Williams CE.
    J Manag Care Pharm; 2007 Sep 09; 13(9):765-77. PubMed ID: 18062728
    [Abstract] [Full Text] [Related]

  • 11. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS, Phillips KA, Gerstenberger EP, Seger AC.
    Ann Intern Med; 2005 Jun 07; 142(11):891-7. PubMed ID: 15941695
    [Abstract] [Full Text] [Related]

  • 12. Pharmacy benefits and the use of drugs by the chronically ill.
    Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch SM.
    JAMA; 2004 May 19; 291(19):2344-50. PubMed ID: 15150206
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE, Siracuse MV, Garis RI.
    Res Social Adm Pharm; 2009 Jun 19; 5(2):133-42. PubMed ID: 19524861
    [Abstract] [Full Text] [Related]

  • 16. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C, Andersen MS, Riggs KR, Alexander GC.
    Health Aff (Millwood); 2015 Mar 19; 34(3):467-76. PubMed ID: 25732498
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.